Acute cholecystitis risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S [2]

Overview

Common risk factors in the development of acute calculous cholecystitis include advancing age, female gender, obesity, and family history. Long periods of fasting, total parental nutrition (TPN), weight loss are the common risk factors for the development of acute acalculous cholecystitis.

Risk Factors

Common risk factors in the development of acute calculous cholecystitis include advancing age, female gender, obesity, and family history. Long periods of fasting, total parental nutrition (TPN), weight loss are the common risk factors for the development of acute acalculous cholecystitis.

Common Risk Factors

Common risk factors in the development of acute calculous cholecystitis are:^[1]^[2]^[3]
- Advancing age
- Female gender
- Obesity
- Multi parity
- Family history
- Genetic factors
- Oral contraceptives
- Diabetes
Common risk factors in the development of acute acalculous cholecystitis are:^[4]
- Long lasting fasting
- Total parenteral nutrition (TPN)
- Weight loss
- Severe burns
- Sepsis

Less Common Risk Factors

Less common risk factors in the development of acute cholecystitis include:^[5]
- AIDS

For the causes of Acute cholecystitis, please click here.

References

↑ Knab LM, Boller AM, Mahvi DM (2014). “Cholecystitis”. Surg. Clin. North Am. 94 (2): 455–70. doi:10.1016/j.suc.2014.01.005. PMID 24679431.
↑ Ruhl CE, Everhart JE (2000). “Association of diabetes, serum insulin, and C-peptide with gallbladder disease”. Hepatology. 31 (2): 299–303. doi:10.1002/hep.510310206. PMID 10655249.
↑ Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL (2006). “Central adiposity, regional fat distribution, and the risk of cholecystectomy in women”. Gut. 55 (5): 708–14. doi:10.1136/gut.2005.076133. PMC 1856127. PMID 16478796.
↑ Jones MW, Ferguson T. “Gallbladder, Cholecystitis, Acalculous”. PMID 29083717.
↑ Kimura Y, Takada T, Kawarada Y, Nimura Y, Hirata K, Sekimoto M, Yoshida M, Mayumi T, Wada K, Miura F, Yasuda H, Yamashita Y, Nagino M, Hirota M, Tanaka A, Tsuyuguchi T, Strasberg SM, Gadacz TR (2007). “Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines”. J Hepatobiliary Pancreat Surg. 14 (1): 15–26. doi:10.1007/s00534-006-1152-y. PMC 2784509. PMID 17252293.

Template:WH Template:WS

[pmid24679431-1] Knab LM, Boller AM, Mahvi DM (2014). “Cholecystitis”. Surg. Clin. North Am. 94 (2): 455–70. doi:10.1016/j.suc.2014.01.005. PMID 24679431.

[pmid10655249-2] Ruhl CE, Everhart JE (2000). “Association of diabetes, serum insulin, and C-peptide with gallbladder disease”. Hepatology. 31 (2): 299–303. doi:10.1002/hep.510310206. PMID 10655249.

[pmid16478796-3] Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL (2006). “Central adiposity, regional fat distribution, and the risk of cholecystectomy in women”. Gut. 55 (5): 708–14. doi:10.1136/gut.2005.076133. PMC 1856127. PMID 16478796.

[pmid29083717-4] Jones MW, Ferguson T. “Gallbladder, Cholecystitis, Acalculous”. PMID 29083717.

[pmid17252293-5] Kimura Y, Takada T, Kawarada Y, Nimura Y, Hirata K, Sekimoto M, Yoshida M, Mayumi T, Wada K, Miura F, Yasuda H, Yamashita Y, Nagino M, Hirota M, Tanaka A, Tsuyuguchi T, Strasberg SM, Gadacz TR (2007). “Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines”. J Hepatobiliary Pancreat Surg. 14 (1): 15–26. doi:10.1007/s00534-006-1152-y. PMC 2784509. PMID 17252293.

[1]

[2]

[3]

[4]

[5]